Odyssey Health (ODYY) Return on Capital Employed (2016 - 2026)
Odyssey Health's (ODYY) quarterly Return on Capital Employed came in at 9.8% in Q2 2026, up 36.0% year-on-year from 7.21% in Q2 2025, and up 38.55% quarter-over-quarter from 7.07% in Q1 2026.
Odyssey Health (ODYY) Return on Capital Employed (2016 - 2026) Analysis & Trends
Odyssey Health's Return on Capital Employed history runs 11 years deep, the most recent figure standing at 9.8% for Q2 2026.
- On a quarterly basis, Return on Capital Employed rose 36.0% year-over-year to 9.8% in Q2 2026; TTM through Apr 2026 was 9.8%, a 36.0% increase from a year earlier, with the FY2025 full-year figure at 15.27%, down 2436.0% from the prior year.
- Return on Capital Employed improved to 9.8% in Q2 2026 per ODYY's latest filing, from 7.07% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 466.87% in Q1 2022 and bottomed at 166.76% in Q1 2024.
- The 5-year median for Return on Capital Employed is 22.6% (2025), against an average of 65.67%.
- Across the five-year window, Return on Capital Employed sank 68784 bps in 2022 and jumped 18032 bps in 2025, its largest moves.
- Year by year, Return on Capital Employed stood at 158.24% in 2022, then sank by 64 bps to 56.91% in 2023, then slumped by 47 bps to 30.4% in 2024, then tumbled by 66 bps to 10.34% in 2025, then fell by 5 bps to 9.8% in 2026.
- Per Business Quant, the three latest ODYY Return on Capital Employed figures stand at 9.8% (Q2 2026), 7.07% (Q1 2026), and 10.34% (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 11.13% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 24.24% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 8.38% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 9.30% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Odyssey Health | 1.08 Mn | 782,508.17 | - | 9.80% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 9.80% |
| Jan 31, 2026 | 7.07% |
| Oct 31, 2025 | 10.34% |
| Jul 31, 2025 | 14.80% |
| Apr 30, 2025 | 9.44% |
| Jan 31, 2025 | 13.55% |
| Oct 31, 2024 | 30.40% |
| Jul 31, 2024 | -141.21% |
| Apr 30, 2024 | -31.20% |
| Jan 31, 2024 | -166.76% |
| Oct 31, 2023 | 56.91% |
| Jul 31, 2023 | 86.18% |
| Apr 30, 2023 | 111.83% |
| Jan 31, 2023 | 160.04% |
| Oct 31, 2022 | 158.24% |
| Jul 31, 2022 | 175.51% |
| Apr 30, 2022 | 210.30% |
| Jan 31, 2022 | 466.87% |
| Oct 31, 2021 | 531.14% |
| Jul 31, 2021 | 676.15% |